INJECTION SITE JOINT INFECTION

This adverse event was reported 0 times

INJECTION SITE JOINT INFECTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 16 0.0052
1 LIDOCAINE HCL 3% 2 0.0044
2 LIDOCAINE HCL 9 0.0035
3 METHYLPREDNISOLONE ACETATE 26 0.0032
4 LIDICAINE 24 0.0005
5 LIDOCAINE, MENTHOL 24 0.0005
6 LIDOCAINE 4% 26 0.0005
7 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 24 0.0004
8 LIDOCAINE HYDROCHLORIDE 24 0.0004
9 GLATIRAMER ACETATE INJECTION 1 0.0002
See all drugs enriched for association with INJECTION SITE JOINT INFECTION

INJECTION SITE JOINT INFECTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Ester Local Anesthetic [EPC] 24 0.0005
1 Amide Local Anesthetic [EPC] 35 0.0004
2 Antiarrhythmic [EPC] 35 0.0004
3 Non-Standardized Chemical Allergen [EPC] 24 0.0003
4 Lipopeptide Antibacterial [EPC] 1 0.0001
5 Folate Analog [EPC] 3 0.0001
6 Vitamin A [EPC] 3 0.0001
7 Nicotinic Acid [EPC] 3 0.0000
8 Antidote [EPC] 3 0.0000
9 Non-Standardized Food Allergenic Extract [EPC] 3 0.0000
See all drug classes enriched for association with INJECTION SITE JOINT INFECTION